Pages that link to "Q36141999"

The following pages link to Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development (Q36141999):

Displaying 49 items.

• Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography (Q26738576) (← links)
• Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis (Q26787117) (← links)
• Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease (Q27011260) (← links)
• Cardiovascular molecular imaging with contrast ultrasound: principles and applications. (Q27021416) (← links)
• Nanotechnology in diagnosis and treatment of coronary artery disease. (Q30362371) (← links)
• Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques (Q30411855) (← links)
• Molecular imaging in cardiovascular disease: Which methods, which diseases? (Q30442045) (← links)
• Molecular imaging of inflammation in atherosclerosis (Q30446268) (← links)
• Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus (Q30587267) (← links)
• Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept (Q33633543) (← links)
• Anti-inflammatory therapies for cardiovascular disease (Q34137872) (← links)
• Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis (Q34161103) (← links)
• Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions (Q34518372) (← links)
• PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis (Q34609062) (← links)
• PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle (Q34632459) (← links)
• Noninvasive detection of macrophages in atherosclerotic lesions by computed tomography enhanced with PEGylated gold nanoparticles (Q34661834) (← links)
• Characterization of a brain permeant fluorescent molecule and visualization of Aβ parenchymal plaques, using real-time multiphoton imaging in transgenic mice (Q35213005) (← links)
• Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging (Q36056187) (← links)
• Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles (Q36396054) (← links)
• Imaging VEGF receptor expression to identify accelerated atherosclerosis (Q36944432) (← links)
• Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques (Q37025651) (← links)
• Immune effector mechanisms implicated in atherosclerosis: from mice to humans (Q37150605) (← links)
• Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes (Q37254899) (← links)
• Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease (Q37386143) (← links)
• Lipid lowering and imaging protease activation in atherosclerosis (Q37710107) (← links)
• Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation (Q37722436) (← links)
• Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice (Q37726950) (← links)
• Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield (Q38091371) (← links)
• Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy (Q38094012) (← links)
• Molecular imaging of macrophage enzyme activity in cardiac inflammation. (Q38204374) (← links)
• PET imaging of inflammation in atherosclerosis (Q38218902) (← links)
• Molecular intravascular imaging approaches for atherosclerosis (Q38249192) (← links)
• Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation (Q38352448) (← links)
• Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions. (Q38495085) (← links)
• Detection and treatment of atherosclerosis using nanoparticles (Q38848673) (← links)
• Gold nanoparticles in cardiovascular imaging (Q39223803) (← links)
• Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography (Q42549859) (← links)
• Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles (Q47138021) (← links)
• Evaluation of [(99m)Tc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice. (Q48124015) (← links)
• Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project? (Q48225540) (← links)
• Development of an inflammation imaging tracer, 111In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE-/- atherosclerosis mouse model (Q50125858) (← links)
• Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1. (Q50355298) (← links)
• The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study (Q50642561) (← links)
• Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE-/- Mice (Q51050077) (← links)
• Molecular Imaging in Drug Discovery and Development. (Q52694389) (← links)
• Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases (Q59793745) (← links)
• Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques (Q61812290) (← links)
• Perspectives on Small Animal Radionuclide Imaging; Considerations and Advances in Atherosclerosis (Q64107238) (← links)
• [Effect of pushing manipulation on Qiaogong acupoint on hemodynamics in cynomolgus monkeys with mild carotid atherosclerotic plaques] (Q89767264) (← links)